Cargando...
Current Therapy of the Patients with MDS: Walking towards Personalized Therapy
Myelodysplastic syndromes (MDS) are characterized by ineffective hematopoiesis, dysplasia and peripheral cytopenias. Nowadays, MDS therapy is selected based on risk. The goals of therapy are different in low-risk and high-risk patients. In low-risk MDS, the goal is to decrease transfusion needs and...
Guardado en:
| Publicado en: | J Clin Med |
|---|---|
| Autores principales: | , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
MDPI
2021
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8153316/ https://ncbi.nlm.nih.gov/pubmed/34068316 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jcm10102107 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|